Sciencast Management LP Acquires 48,676 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Sciencast Management LP lifted its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 236.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 69,276 shares of the medical instruments supplier's stock after acquiring an additional 48,676 shares during the period. Sciencast Management LP's holdings in DENTSPLY SIRONA were worth $1,315,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Xponance Inc. raised its holdings in shares of DENTSPLY SIRONA by 7.3% in the fourth quarter. Xponance Inc. now owns 33,034 shares of the medical instruments supplier's stock valued at $627,000 after purchasing an additional 2,235 shares during the last quarter. Counterpoint Mutual Funds LLC bought a new position in shares of DENTSPLY SIRONA during the 4th quarter worth approximately $299,000. Signaturefd LLC lifted its position in shares of DENTSPLY SIRONA by 513.3% during the 4th quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier's stock worth $84,000 after buying an additional 3,706 shares in the last quarter. Royce & Associates LP purchased a new position in shares of DENTSPLY SIRONA in the 4th quarter worth approximately $220,000. Finally, Envestnet Portfolio Solutions Inc. increased its position in shares of DENTSPLY SIRONA by 82.9% during the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 15,901 shares of the medical instruments supplier's stock valued at $302,000 after acquiring an additional 7,206 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company's stock.

Remove Ads

DENTSPLY SIRONA Price Performance

NASDAQ XRAY traded up $0.04 during trading hours on Thursday, hitting $15.64. The company had a trading volume of 2,814,665 shares, compared to its average volume of 3,002,911. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The firm has a market capitalization of $3.11 billion, a price-to-earnings ratio of -7.56, a PEG ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA Inc. has a 52 week low of $14.78 and a 52 week high of $33.42. The firm has a 50 day simple moving average of $17.81 and a 200 day simple moving average of $20.33.

DENTSPLY SIRONA Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be given a $0.16 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.09%. DENTSPLY SIRONA's dividend payout ratio (DPR) is currently -14.07%.

Insider Activity at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier purchased 15,142 shares of the business's stock in a transaction on Monday, March 3rd. The stock was purchased at an average cost of $16.51 per share, with a total value of $249,994.42. Following the acquisition, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.52% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several research firms have weighed in on XRAY. Robert W. Baird cut their price objective on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research report on Friday, February 28th. UBS Group decreased their price objective on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating for the company in a report on Tuesday, December 3rd. Jefferies Financial Group cut shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and dropped their target price for the company from $30.00 to $20.00 in a research note on Thursday, January 23rd. Wells Fargo & Company decreased their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a research note on Friday, February 28th. Finally, Barrington Research lowered their price target on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating on the stock in a report on Friday, February 28th. Twelve analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $23.33.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.